These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
601 related articles for article (PubMed ID: 18684007)
1. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques. Nuttall J; Kashuba A; Wang R; White N; Allen P; Roberts J; Romano J Antimicrob Agents Chemother; 2012 Jan; 56(1):103-9. PubMed ID: 21986823 [TBL] [Abstract][Full Text] [Related]
4. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. García-Lerma JG; Otten RA; Qari SH; Jackson E; Cong ME; Masciotra S; Luo W; Kim C; Adams DR; Monsour M; Lipscomb J; Johnson JA; Delinsky D; Schinazi RF; Janssen R; Folks TM; Heneine W PLoS Med; 2008 Feb; 5(2):e28. PubMed ID: 18254653 [TBL] [Abstract][Full Text] [Related]
5. The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques. Singer R; Derby N; Rodriguez A; Kizima L; Kenney J; Aravantinou M; Chudolij A; Gettie A; Blanchard J; Lifson JD; Piatak M; Fernández-Romero JA; Zydowsky TM; Robbiani M J Virol; 2011 Jun; 85(11):5504-12. PubMed ID: 21411526 [TBL] [Abstract][Full Text] [Related]
6. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. Van Rompay KK; Marthas ML; Lifson JD; Berardi CJ; Vasquez GM; Agatep E; Dehqanzada ZA; Cundy KC; Bischofberger N; Pedersen NC AIDS Res Hum Retroviruses; 1998 Jun; 14(9):761-73. PubMed ID: 9643376 [TBL] [Abstract][Full Text] [Related]
7. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA. Van Rompay KK; Miller MD; Marthas ML; Margot NA; Dailey PJ; Canfield DR; Tarara RP; Cherrington JM; Aguirre NL; Bischofberger N; Pedersen NC J Virol; 2000 Feb; 74(4):1767-74. PubMed ID: 10644348 [TBL] [Abstract][Full Text] [Related]
8. Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine. Parikh UM; Dobard C; Sharma S; Cong ME; Jia H; Martin A; Pau CP; Hanson DL; Guenthner P; Smith J; Kersh E; Garcia-Lerma JG; Novembre FJ; Otten R; Folks T; Heneine W J Virol; 2009 Oct; 83(20):10358-65. PubMed ID: 19656878 [TBL] [Abstract][Full Text] [Related]
9. Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallenge. Lifson JD; Piatak M; Cline AN; Rossio JL; Purcell J; Pandrea I; Bischofberger N; Blanchard J; Veazey RS J Med Primatol; 2003 Aug; 32(4-5):201-10. PubMed ID: 14498980 [TBL] [Abstract][Full Text] [Related]
10. Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors. García-Lerma JG; Aung W; Cong ME; Zheng Q; Youngpairoj AS; Mitchell J; Holder A; Martin A; Kuklenyik S; Luo W; Lin CY; Hanson DL; Kersh E; Pau CP; Ray AS; Rooney JF; Lee WA; Heneine W J Virol; 2011 Jul; 85(13):6610-7. PubMed ID: 21525346 [TBL] [Abstract][Full Text] [Related]
11. Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection. Tsai CC; Emau P; Sun JC; Beck TW; Tran CA; Follis KE; Bischofberger N; Morton WR J Med Primatol; 2000 Aug; 29(3-4):248-58. PubMed ID: 11085587 [TBL] [Abstract][Full Text] [Related]
12. Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue. Dobard C; Sharma S; Martin A; Pau CP; Holder A; Kuklenyik Z; Lipscomb J; Hanson DL; Smith J; Novembre FJ; García-Lerma JG; Heneine W J Virol; 2012 Jan; 86(2):718-25. PubMed ID: 22072766 [TBL] [Abstract][Full Text] [Related]
13. Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection. Van Rompay KK; Berardi CJ; Aguirre NL; Bischofberger N; Lietman PS; Pedersen NC; Marthas ML AIDS; 1998 Jun; 12(9):F79-83. PubMed ID: 9662190 [TBL] [Abstract][Full Text] [Related]
15. SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy. Carruth LM; Zink MC; Tarwater PM; Miller MD; Li M; Queen LA; Mankowski JL; Shen A; Siliciano RF; Clements JE J Med Primatol; 2005 Jun; 34(3):109-21. PubMed ID: 15860119 [TBL] [Abstract][Full Text] [Related]
16. Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal. Van Rompay KK; Trott KA; Jayashankar K; Geng Y; LaBranche CC; Johnson JA; Landucci G; Lipscomb J; Tarara RP; Canfield DR; Heneine W; Forthal DN; Montefiori D; Abel K Retrovirology; 2012 Jul; 9():57. PubMed ID: 22805180 [TBL] [Abstract][Full Text] [Related]
17. Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir. Dobard CW; Taylor A; Sharma S; Anderson PL; Bushman LR; Chuong D; Pau CP; Hanson D; Wang L; Garcia-Lerma JG; McGowan I; Rohan L; Heneine W J Infect Dis; 2015 Dec; 212(12):1988-95. PubMed ID: 26071566 [TBL] [Abstract][Full Text] [Related]
18. Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. Kersh EN; Luo W; Adams DR; Mitchell J; Garcia-Lerma JG; Heneine W; Folks TM; Butera S; Otten RA AIDS Res Hum Retroviruses; 2008 Apr; 24(4):543-6. PubMed ID: 18370590 [TBL] [Abstract][Full Text] [Related]
19. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges. Smith JM; Rastogi R; Teller RS; Srinivasan P; Mesquita PM; Nagaraja U; McNicholl JM; Hendry RM; Dinh CT; Martin A; Herold BC; Kiser PF Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16145-50. PubMed ID: 24043812 [TBL] [Abstract][Full Text] [Related]
20. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. Abel K; La Franco-Scheuch L; Rourke T; Ma ZM; De Silva V; Fallert B; Beckett L; Reinhart TA; Miller CJ J Virol; 2004 Jan; 78(2):841-54. PubMed ID: 14694116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]